Could this be the case of a blown-up long-term opportunity? Nevro Corp (NVRO)

Nevro Corp [NVRO] stock is trading at $4.03, up 22.49%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NVRO shares have gain 8.63% over the last week, with a monthly amount drifted -7.14%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Nevro Corp [NYSE: NVRO] stock has seen the most recent analyst activity on December 03, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $5. Previously, Morgan Stanley downgraded its rating to Underweight on December 02, 2024, and dropped its price target to $4. On August 09, 2024, upgrade upgraded it’s rating to Neutral. Wolfe Research upgraded its rating to a Peer Perform. Wells Fargo downgraded its rating to a Underweight and reduced its price target to $5.50 on August 07, 2024. JP Morgan downgraded its rating to Underweight for this stock on August 07, 2024. In a note dated August 07, 2024, JMP Securities downgraded an Mkt Perform rating on this stock.

Nevro Corp [NVRO] stock has fluctuated between $3.16 and $20.41 over the past year. Currently, Wall Street analysts expect the stock to reach $5.84 within the next 12 months. Nevro Corp [NYSE: NVRO] shares were valued at $4.03 at the most recent close of the market. An investor can expect a potential return of 44.91% based on the average NVRO price forecast.

Analyzing the NVRO fundamentals

Nevro Corp [NYSE:NVRO] reported sales of 419.15M for the trailing twelve months, which represents a drop of -6.69%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.25 and Total Capital is -0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.81.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.70 points at the first support level, and at 3.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.23, and for the 2nd resistance point, it is at 4.42.

Ratios To Look Out For

For context, Nevro Corp’s Current Ratio is 5.02. As well, the Quick Ratio is 3.76, while the Cash Ratio is 0.75. Considering the valuation of this stock, the price to sales ratio is 0.36, the price to book ratio is 0.55.

Related Posts